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Table
Prescription of celecoxib and other NSAIDs for OA: Stratiﬁed by active patient
request
Active
Request
Celecoxib NSAID,
not Cox-2
Celecoxib OR
non-selective
Neither
Yes 51 (53%) 28 (29%) 79 (82%) 17 (18%)
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RACE INTERACTIONS AND FOOT FUNCTION IN OLDER ADULTS: THE
JOHNSTON COUNTY OSTEOARTHRITIS PROJECT
M.T. Hannan y, A.B. Dufour z, Y.M. Golightly x, V.A. Casey z,
T.J. Hagedorn z, J.L. Riskowski y, H.J. Hillstrom k, J.M. Jordan x. yHebrew
SeniorLife & Harvard Med. Sch., Roslindale, MA, USA; zHebrew
SeniorLife, Roslindale, MA, USA; xUniv. of North Carolina, Chapel Hill,
NC, USA; kHosp. for Special Surgery, NY, USA
Purpose: Center of pressure excursion index (CPEI), a measure that
characterizes pronation and supination, may be a useful indicator of
foot function. Data from the predominantly Caucasian Framingham
Foot Study have shown that CPEI differed signiﬁcantly by age and sex.
The purpose of this study was to examine whether demographic and
clinical traits were associated with CPEI in a large bi-racial cohort of
men and women  50 years of age.
Methods: Of the 1695 Johnston County Osteoarthritis Project partici-
pants clinically evaluated in 2006-2010, 1466 were enrolled in
a comprehensive foot study. As part of the exam, participants were
instructed towalk at a self-selected pace over a TekscanMatscan system
(Tekscan, Inc., Boston) using the two-step method. Two plantar pres-
sure scans were recorded for each foot. Custom software was used to
calculate CPEI and was averaged for each foot; the foot with the aver-
aged CPEI value farthest from themedianwas used in analyses. A higher
CPEI value indicates a more supinated foot, while lower CPEI indicates
a more pronated foot. Characteristics included sex, age (< 65 or  65
years), body mass index (BMI, <30 or  30 kg/m2), and race (Caucasian
or African-American). Student's t-test was used to identify those factors
associated with differences in mean CPEI for the sample and stratiﬁed
by sex. Linear regression was used to evaluate interactions of contin-
uous factors (age and BMI) by race.
Results: Participants (67% women, 29% African-American) had mean
age of 68 years and mean BMI of 31 kg/m2. The mean CPEI was
smaller among women than men (p<0.0001, Table). In the total
sample, CPEI differed by age group with participants 65+ yrs having
lower CPEI (p<0.0001), indicating a tendency toward more pronation
with age. When this difference was stratiﬁed by sex (Table), women
65+ yrs continued to have lower CPEI (p¼0.0002); men had a similar
result albeit with borderline statistical signiﬁcance (p¼0.07). CPEI did
not differ by BMI or by race. However, signiﬁcant interactions were
noted between race and continuous age (p¼0.022), as well as
between race and continuous BMI (p¼0.026), with CPEI in women
only. While older women of either race had lower CPEI (as did those
with higher BMI), the difference was twice as large in African-
American (w3.2 CPEI units, p¼0.002) than Caucasian women (w1.5
units, p¼0.02).
Conclusions: Similar to results reported in the Caucasian Framingham
Foot Study, we found signiﬁcant differences in mean CPEI that indicate
over-pronation for those aged 65+ yrs and for women, but found no
link between CPEI and BMI. While there was no main effect by race for
the categorical data, the interactions in women by race imply that
there may be a greater age effect towards pronation in older African-
American women. This might indicate more foot pathology, an
underlying genetic component of foot function or perhaps even more
need for treatment of the pronated foot in this group.Table
T-tests for associations between demographic and clinical variables and CPEI in men and women
Males N Mean CPEI Standard Deviation p Females N Mean CPEI Standard Deviation p
Sex 481 16.3 8.4 Sex 985 14.4 8.8 <.0001
Age < 65 214 17.1 8.8 0.07 Age < 65 384 15.7 8.5 0.0002
Age  65 267 15.7 7.9 Age  65 601 13.6 8.9
BMI < 30 241 16.4 8.6 0.78 BMI < 30 477 14.0 9.1 0.13
BMI  30 240 16.2 8.1 BMI  30 508 14.8 8.4
Caucasian 363 16.6 8.2 0.13 Caucasian 671 14.4 8.7 0.72
African-Am 118 15.3 8.8 African-Am 314 14.6 9.1
No 23 (24%) 40 (42%) 63 (66%) 33 (34%)286
THE ACTIVATED PATIENT INFLUENCES PRIMARY CARE PHYSICIANS'
PRESCRIPTIONS OF CELEBREX FOR OSTEOARTHRITIS
J.N. Katz y, L.D. Marceau z, F.L. Trachtenberg z, M.A. Fischer y, J. Yu z,
J.B. McKinlay z, J.B. McKinlay z. yBrigham and Women's Hosp., Boston,
MA, USA; zNew England Res. Inst., Watertown, MA, USAPurpose: Direct to consumer marketing of medications is intended to
“activate” patients to request the advertised medication from their
physicians. There is limited data on the extent to which physicians alter
prescribing patterns in response to speciﬁc requests from activated
patients.
Methods: We performed a factorial experiment in which primary care
physicians viewed clinically authentic videotapes of “patients” presenting
with symptomatic knee osteoarthritis (OA). The “patients” were played
by professional actors who differed by sex, race (white, Black, Hispanic)
and SES (higher, lower).192 primary care physicians working primarily in
Illinois were recruited to participate. Each physician viewed one
vignette of a patient with typical symptoms of knee OA lasting for
several months. In one half of vignettes the patient was ‘activated’ and
asked: “I've seen ads for Celebrex and it looks just like what I need/A
woman I work with takes it and she said it really works for her/so, I really
want to try that.” The non activated patients requested help with their
pain but did not ask for any speciﬁc medications: “I just want something
to make it better.” Activated and nonactivated vignettes were balanced
on sex, race and SES. Physicians were balanced by sex and years of
experience. After viewing the videotape, the physicians completed
a questionnaire in which they indicated the treatment(s) they would
likely order. We examined the association between patient character-
istics, particularly activated vs. non-activated, and the medications the
physicians said they would prescribe (celecoxib, non-selective NSAIDs,
other) using a multivariate ANOVA model.
Results: 53% of the PCPs presented with a vignette including an active
request for celecoxib reported that they would prescribe celecoxib, as
compared with 24% of physicians seeing the identical vignette without
an active medication request (p<0.0001; Table). Physicians receiving an
active request for celecoxib were less likely to report that they would
prescribe a non-selective NSAID (29%) than physicians whose simulated
patients did not request celecoxib (42%; p¼0.06). Further, physicians
who received an active request for celecoxib prescribed either a COX-2
OR a traditional NSAID for 82% of vignettes, compared to 66% of
physicians who did not receive an active request (p¼0.004). The asso-
ciations between active request and physician prescribing patterns
were not inﬂuenced by patient characteristics (gender, race, SES) or
physician characteristics (gender, experience).
Conclusions: Physicians presented with an activated request for cele-
coxib by a patient with typical knee OA were more than twice as likely
to prescribe celecoxib compared to physicians encountering a non-
activated patient who provided the same clinical history and they were
also considerably more likely to prescribe any NSAID (selective or non-
selective) . Given the higher price, increased risk of cardiovascular
toxicity and similar efﬁcacy of celecoxib compared to non-selective
NSAIDs, these ﬁndings suggest that patient activation may increase
health care costs and compromise appropriateness of prescribing.287
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